CY1109262T1 - Μεθοδος μειωσης α,β-ακορεστων κετονων σε οπιοειδεις συνθεσεις - Google Patents

Μεθοδος μειωσης α,β-ακορεστων κετονων σε οπιοειδεις συνθεσεις

Info

Publication number
CY1109262T1
CY1109262T1 CY20091100790T CY091100790T CY1109262T1 CY 1109262 T1 CY1109262 T1 CY 1109262T1 CY 20091100790 T CY20091100790 T CY 20091100790T CY 091100790 T CY091100790 T CY 091100790T CY 1109262 T1 CY1109262 T1 CY 1109262T1
Authority
CY
Cyprus
Prior art keywords
reducing
uncontinued
cetones
optional compositions
diimide
Prior art date
Application number
CY20091100790T
Other languages
English (en)
Inventor
Robert J Kupper
Original Assignee
Euro-Celtique S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Euro-Celtique S.A. filed Critical Euro-Celtique S.A.
Publication of CY1109262T1 publication Critical patent/CY1109262T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/02—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with oxygen atoms attached in positions 3 and 6, e.g. morphine, morphinone

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Rheumatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Η παρούσα εφεύρεση απευθύνεται σε μία διεργασία για τη μείωση του επιπέδου α,β-ακόρεστης κετόνης σε μία οπιοειδή αναλγητική σύνθεση με υδρογόνωση με διιμίδιο ή πρόγονο διιμιδίου.
CY20091100790T 2005-03-04 2009-07-23 Μεθοδος μειωσης α,β-ακορεστων κετονων σε οπιοειδεις συνθεσεις CY1109262T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US65879105P 2005-03-04 2005-03-04
EP06707309A EP1861405B1 (en) 2005-03-04 2006-02-27 Method of reducing alpha, beta- unsaturated ketones in opioid compositions

Publications (1)

Publication Number Publication Date
CY1109262T1 true CY1109262T1 (el) 2014-07-02

Family

ID=36301669

Family Applications (2)

Application Number Title Priority Date Filing Date
CY20091100790T CY1109262T1 (el) 2005-03-04 2009-07-23 Μεθοδος μειωσης α,β-ακορεστων κετονων σε οπιοειδεις συνθεσεις
CY20111100129T CY1111241T1 (el) 2005-03-04 2011-02-03 Μεθοδος μειωσης α,β-ακορεστων κετονων σε οπιοεiδεις συνθεσεις

Family Applications After (1)

Application Number Title Priority Date Filing Date
CY20111100129T CY1111241T1 (el) 2005-03-04 2011-02-03 Μεθοδος μειωσης α,β-ακορεστων κετονων σε οπιοεiδεις συνθεσεις

Country Status (19)

Country Link
US (1) US7939543B2 (el)
EP (2) EP1861405B1 (el)
JP (1) JP5314894B2 (el)
KR (1) KR100941761B1 (el)
CN (1) CN101133062B (el)
AT (2) ATE487722T1 (el)
CA (1) CA2598774C (el)
CY (2) CY1109262T1 (el)
DE (2) DE602006006558D1 (el)
DK (2) DK2112153T3 (el)
ES (2) ES2326491T3 (el)
HK (2) HK1111695A1 (el)
HR (2) HRP20090387T1 (el)
ME (2) ME01184B (el)
PL (2) PL2112153T3 (el)
PT (2) PT1861405E (el)
RS (2) RS51131B (el)
SI (2) SI2112153T1 (el)
WO (1) WO2006094672A1 (el)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7776314B2 (en) 2002-06-17 2010-08-17 Grunenthal Gmbh Abuse-proofed dosage system
US8075872B2 (en) 2003-08-06 2011-12-13 Gruenenthal Gmbh Abuse-proofed dosage form
DE102005005446A1 (de) 2005-02-04 2006-08-10 Grünenthal GmbH Bruchfeste Darreichungsformen mit retardierter Freisetzung
US20070048228A1 (en) 2003-08-06 2007-03-01 Elisabeth Arkenau-Maric Abuse-proofed dosage form
NZ545202A (en) * 2003-08-06 2010-03-26 Gruenenthal Chemie Abuse-proofed dosage form comprising opiods and a high molecular weight polyethylene oxide
DE10336400A1 (de) 2003-08-06 2005-03-24 Grünenthal GmbH Gegen Missbrauch gesicherte Darreichungsform
DE10361596A1 (de) 2003-12-24 2005-09-29 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
TWI483944B (zh) 2004-03-30 2015-05-11 Euro Celtique Sa 含有小於２５ｐｐｍ１４-羥可待因酮之羥可酮鹽酸鹽組成物、醫藥劑型、延遲釋出口服劑型及醫藥上可以接受的包裝
DE102004032049A1 (de) * 2004-07-01 2006-01-19 Grünenthal GmbH Gegen Missbrauch gesicherte, orale Darreichungsform
DE102005005449A1 (de) 2005-02-04 2006-08-10 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
CA2644095A1 (en) * 2006-03-02 2007-09-13 Mallinckrodt Inc. Processes for preparing morphinan-6-one products with low levels of alpha, beta-unsaturated ketone compounds
WO2008070656A2 (en) * 2006-12-04 2008-06-12 Noramco, Inc Process for reducing impurities in oxycodone base
JP2010511726A (ja) * 2006-12-04 2010-04-15 ノランコ・インコーポレーテツド １４−ヒドロキシコデイノンの濃度が低いオキシコドンの製造方法
DE102007011485A1 (de) 2007-03-07 2008-09-11 Grünenthal GmbH Darreichungsform mit erschwertem Missbrauch
JP5373764B2 (ja) * 2007-04-16 2013-12-18 マリンクロッド エルエルシー 触媒性水素転移反応を使用する新規なオピエート還元
FR2923484B1 (fr) 2007-11-09 2012-11-09 Sanofi Aventis Procede de preparation de composes morphiniques
EP2249811A1 (en) 2008-01-25 2010-11-17 Grünenthal GmbH Pharmaceutical dosage form
EP2262484B1 (en) * 2008-03-11 2013-01-23 Depomed, Inc. Gastric retentive extended-release dosage forms comprising combinations of a non-opioid analgesic and an opioid analgesic
US8372432B2 (en) 2008-03-11 2013-02-12 Depomed, Inc. Gastric retentive extended-release dosage forms comprising combinations of a non-opioid analgesic and an opioid analgesic
CN102123701B (zh) 2008-05-09 2013-03-27 格吕伦塔尔有限公司 使用喷雾冻凝步骤制备中间粉末制剂以及最终固体剂型的方法
JP2012533585A (ja) 2009-07-22 2012-12-27 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング 酸化感受性オピオイドのための不正使用防止剤形
NZ596667A (en) * 2009-07-22 2013-09-27 Gruenenthal Chemie Hot-melt extruded controlled release dosage form
US20110052685A1 (en) * 2009-08-31 2011-03-03 Depomed, Inc. Gastric retentive pharmaceutical compositions for immediate and extended release of acetaminophen
US8597681B2 (en) 2009-12-22 2013-12-03 Mallinckrodt Llc Methods of producing stabilized solid dosage pharmaceutical compositions containing morphinans
US9198861B2 (en) 2009-12-22 2015-12-01 Mallinckrodt Llc Methods of producing stabilized solid dosage pharmaceutical compositions containing morphinans
EP2377866B1 (en) 2010-03-23 2014-02-26 Siegfried AG Preparation of low impurity opiates in a continuous flow reactor
JP2013529595A (ja) 2010-06-11 2013-07-22 ローズ テクノロジーズ 第３級アミンのｎ−脱アルキル化方法
EP2995614B8 (en) 2010-06-11 2018-03-28 Rhodes Technologies Inc. Transition metal-catalyzed processes for the preparation of n-allyl compounds and use thereof
CA2808219C (en) 2010-09-02 2019-05-14 Gruenenthal Gmbh Tamper resistant dosage form comprising inorganic salt
KR20130137627A (ko) 2010-09-02 2013-12-17 그뤼넨탈 게엠베하 음이온성 중합체를 포함하는 내변조성 투여형
US8658631B1 (en) 2011-05-17 2014-02-25 Mallinckrodt Llc Combination composition comprising oxycodone and acetaminophen for rapid onset and extended duration of analgesia
US8858963B1 (en) 2011-05-17 2014-10-14 Mallinckrodt Llc Tamper resistant composition comprising hydrocodone and acetaminophen for rapid onset and extended duration of analgesia
US8741885B1 (en) 2011-05-17 2014-06-03 Mallinckrodt Llc Gastric retentive extended release pharmaceutical compositions
NO2736497T3 (el) 2011-07-29 2018-01-20
CN103841964A (zh) 2011-07-29 2014-06-04 格吕伦塔尔有限公司 提供药物立即释放的抗破碎片剂
CA2864949A1 (en) 2012-02-28 2013-09-06 Grunenthal Gmbh Tamper-resistant dosage form comprising pharmacologically active compound and anionic polymer
CA2868142A1 (en) 2012-04-18 2013-10-24 Grunenthal Gmbh Tamper resistant and dose-dumping resistant pharmaceutical dosage form
US10064945B2 (en) 2012-05-11 2018-09-04 Gruenenthal Gmbh Thermoformed, tamper-resistant pharmaceutical dosage form containing zinc
ES2846735T3 (es) * 2013-03-15 2021-07-29 Johnson Matthey Plc Solvato metanólico de sulfato de morfina, procedimientos para hacer el mismo y las composiciones relacionadas y métodos de tratamiento del dolor
AU2014273226B2 (en) 2013-05-29 2019-06-27 Grunenthal Gmbh Tamper resistant dosage form with bimodal release profile
WO2015004245A1 (en) 2013-07-12 2015-01-15 Grünenthal GmbH Tamper-resistant dosage form containing ethylene-vinyl acetate polymer
BR112016010482B1 (pt) 2013-11-26 2022-11-16 Grünenthal GmbH Preparação de uma composição farmacêutica em pó por meio de criomoagem
US9062062B1 (en) 2013-12-18 2015-06-23 Cody Laboratories, Inc. Synthesis of oxycodone hydrochloride
US8846923B1 (en) 2013-12-18 2014-09-30 Cody Laboratories, Inc. Preparation of 14-hydroxycodeinone sulfate
US10227354B2 (en) 2013-12-18 2019-03-12 Cody Laboratories, Inc. Conversion of oxycodone base to oxycodone hydrochloride
WO2015173195A1 (en) 2014-05-12 2015-11-19 Grünenthal GmbH Tamper resistant immediate release capsule formulation comprising tapentadol
AU2015266117A1 (en) 2014-05-26 2016-11-24 Grunenthal Gmbh Multiparticles safeguarded against ethanolic dose-dumping
CA2954600A1 (en) 2014-07-09 2016-01-14 Rhodes Technologies Reduction of alpha, beta-unsaturated ketone levels in morphinan derivative compositions
EP3285745A1 (en) 2015-04-24 2018-02-28 Grünenthal GmbH Tamper-resistant dosage form with immediate release and resistance against solvent extraction
EP3346991A1 (en) 2015-09-10 2018-07-18 Grünenthal GmbH Protecting oral overdose with abuse deterrent immediate release formulations

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3812312A (en) * 1971-11-15 1974-05-21 Chrysler Corp Impact velocity sensor switch with linearly movable controller
US5869669A (en) * 1996-07-26 1999-02-09 Penick Corporation Preparation of 14-hydroxynormorphinones from normorphinone dienol acylates
GB9713703D0 (en) 1997-06-30 1997-09-03 Johnson Matthey Plc Preparation of opiates
US6177567B1 (en) * 1999-10-15 2001-01-23 Boehringer Ingelheim Chemicals, Inc. Method for preparing oxycodone
TWI483944B (zh) * 2004-03-30 2015-05-11 Euro Celtique Sa 含有小於２５ｐｐｍ１４-羥可待因酮之羥可酮鹽酸鹽組成物、醫藥劑型、延遲釋出口服劑型及醫藥上可以接受的包裝

Also Published As

Publication number Publication date
KR100941761B1 (ko) 2010-02-11
HK1135107A1 (en) 2010-05-28
DK1861405T3 (da) 2009-07-20
CA2598774A1 (en) 2006-09-14
KR20070108931A (ko) 2007-11-13
US7939543B2 (en) 2011-05-10
WO2006094672A1 (en) 2006-09-14
HRP20090387T1 (en) 2009-08-31
ATE430153T1 (de) 2009-05-15
PL1861405T3 (pl) 2009-10-30
RS51131B (sr) 2010-10-31
DK2112153T3 (da) 2011-02-14
SI2112153T1 (sl) 2011-02-28
RS51568B (en) 2011-08-31
ME01184B (me) 2013-03-20
PT2112153E (pt) 2010-12-17
SI1861405T1 (sl) 2009-10-31
CN101133062A (zh) 2008-02-27
DE602006006558D1 (de) 2009-06-10
HK1111695A1 (en) 2008-08-15
JP2008531626A (ja) 2008-08-14
HRP20110078T1 (hr) 2011-03-31
CA2598774C (en) 2010-12-21
ES2355870T3 (es) 2011-03-31
PT1861405E (pt) 2009-07-27
ES2326491T3 (es) 2009-10-13
CY1111241T1 (el) 2015-06-11
ME01594B (me) 2014-09-20
ATE487722T1 (de) 2010-11-15
US20080132702A1 (en) 2008-06-05
CN101133062B (zh) 2014-08-06
EP2112153A1 (en) 2009-10-28
PL2112153T3 (pl) 2011-04-29
DE602006018208D1 (de) 2010-12-23
EP1861405B1 (en) 2009-04-29
EP2112153B1 (en) 2010-11-10
EP1861405A1 (en) 2007-12-05
JP5314894B2 (ja) 2013-10-16

Similar Documents

Publication Publication Date Title
CY1109262T1 (el) Μεθοδος μειωσης α,β-ακορεστων κετονων σε οπιοειδεις συνθεσεις
MA32301B1 (fr) 1-aryl-3-amino-alcoxypyrazoles comme ligands de sigma augmentant l'effet analgesique d'opioides et attenuant la dependance a ceux-ci
DE602006012801D1 (de) Verwendung von 1- benzyl-1- hydroxy-2, 3-diamino-propylaminen, 3-benzyl-3 hydroxy-2-amino-propionsäureamiden und verwandten verbindungen als analgetika
EA201170295A1 (ru) ИНГИБИТОРЫ сМЕТ
DE602007003197D1 (de) Verfahren zur herstellung von morphinan-6-on-produkten mit geringen konzentrationen von alpha-, beta-ungesättigten ketonverbindungen
EA201100748A1 (ru) Пиразиновые соединения в качестве ингибиторов фосфодиэстеразы 10
DE602006009652D1 (de) Eine herstellungsmethode von entacapon-enthaltenden granulaten für orale dosierformen
ECSP088918A (es) Derivados de alcanos azabicíclicos sustituidos con bicicloheterociclos fusionados
ATE542803T1 (de) Verfahren zur herstellung von dihydrochinazolinen
NO20074843L (no) Nye salter av 6-heterocyklylsubstituerte heksahydrofenantridinderivater
ME00996B (me) Trans-klomifen za liječenje metaboličkog sindroma
ATE539054T1 (de) Verfahren zur herstellung von dihydropyrrolderivaten als zwischenprodukte
CY1115029T1 (el) Μεθοδος για τον καθαρισμο υδατικου ρευματος που προερχεται απο την αντιδραση fischer-tropsch
ATE526302T1 (de) Verfahren zur aufreinigung von hexafluorpropendimeren
ATE423775T1 (de) Verfahren zur herstellung von lactonen
MX2011006845A (es) Inhibidores de glyt1 biciclicos 3.1.0 y metodos para elaboracion y utilizacion de los mismos.
DK2004149T3 (da) Farmaceutiske sammensætninger indeholdende leflunomid
DK2038341T3 (da) Sammensætning med en polymer og en oxidationskatalysator
IL188917A0 (en) 2-hydroxy-propionic acid derivatives and 3-hydroxy-benzofuran-2-one derivatives with affinity for the gaba-b-receptor
UA94743C2 (ru) Способ получения производных лизобактина